Role of residue Y99 in tissue plasminogen activator

Protein Science

Volumn 9, Issue 3, 2000, Pages 619-622

  Vindigni, Alessandro ^a   Winfield, Mollie ^a   Ayala, Youhna M ^a   Di Cera, Enrico ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Kinetics; Protein engineering; Serine proteases

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

AMINO ACID SEQUENCE; ARTICLE; BLOOD CLOT LYSIS; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME KINETICS; ESCHERICHIA COLI; FIBRINOLYSIS; GENETIC ENGINEERING; NONHUMAN; PRIORITY JOURNAL;

ESCHERICHIA COLI; FELIS CATUS; TRIXIS;

EID: 0034107933     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.9.3.619     Document Type: Article

References (21)

1. Collen D, Lijnen HR. 1995. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy. Thromb Hemost 74:167-171.
2. Collins R, Peto R, Baigent C, Sleight P. 1997. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. Drug Therapy 336:847-860.
3. Dang QD, Di Cera E. 1997. Chromogenic substrates selective for activated protein C. Blood 89:2220-2222.
4. Dang QD, Frieden C. 1997. New PC versions of the kinetic-simulation and fitting programs, KINSIM and FITSIM. Trends Biochem Sci 22:317.
5. Di Cera E. 1998. Anticoagulant thrombins. Trends Cardiovasc Med 8:340-350.
6. Egan JO, Kalafatis M, Mann KG. 1997. The effect of Arg306 → Ala and Arg506 → Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S. Protein Sci 6:2016-2027.
7. Higgins DL, Lamb MC, Young SL, Powers DB, Anderson S. 1990. The effect of the one-chain to two-chain conversion in tissue plasminogen activator: Characterization of mutation at position 275. Thromb Res 57:527-539.
8. 2-antiplasmin, a serine proteases inhibitor (serpin). J Biol Chem 262:1659-1664.
9. Hopfner KP, Lang A, Karcher A, Sichler K, Kopetzki E, Brandstetter H, Huber R, Bode W, Engh RA. 1999. Coagulation factor IXa: The relaxed conformation of Tyr99 blocks substrate binding. Structure Fold Des 7:989-996.
10. Hoylaerts M, Rijken DC, Lijnen HR, Collen D. 1982. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem 257:2912-2919.
11. Kalafatis M, Rand M, Mann KG. 1994. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 269:31869-31880.
12. Lamba D, Bauer M, Huber R, Fischer S, Rudolph R, Kohnert U, Bode W. 1996. The 2.3 Å crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator. J Mol Biol 258:117-135.
13. Ludlam CA, Bennett B, Fox KAA, Lowe GDO, Reid AW. 1995. Guidelines for the use of thrombolytic therapy. Blood Coagul Fibrinol 6:273-285.
14. Madison EL, Goldsmith EJ, Gerard RD, Gething MJH, Sambrook JF. 1989. Serpin-resistant mutants of human tissue-type plasminogen activator. Nature 339:721-724.
15. Madison EL, Goldsmith EJ, Gerard RD, Gething MJH, Sambrook JF, Bassel-Duby RS. 1990. Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor I. Proc Nat Acad Sci USA 87:3530-3533.
16. Renatus M, Bode W, Huber R, Sturzebecher J, Stubbs MT. 1998. Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: Implications for the inhibition of factor Xa, tPA, and urokinase. J Med Chem 41:5445-5456.
17. Rezaie AR. 1997. Role of Leu99 of thrombin in determining the P2 specificity of serpins. Biochemistry 36:7437-7446.
18. Rezaie AR. 1998. Reactivities of the S2 and S3 subsite residues of thrombin with the native and heparin-induced conformers of antithrombin. Protein Sci 7:349-357.
19. Tsiang M, Jain AK, Gibbs CS. 1997. Functional requirements for inhibition of thrombin by antithrombin III in the presence and absence of heparin. J Biol Chem 272:12024-12029.
20. Vindigni A, Di Cera E. 1996. Release of fibrinopeptides by the slow and fast forms of thrombin. Biochemistry 35:4417-4426.
21. Vindigni A, Di Cera E. 1998. Role of P225 and the C136-C201 disulfide bond in tissue plasminogen activator. Protein Sci 7:1728-1737.